SRXH (STOCKS)
SRX Health Solutions, Inc.
$0.145100
-0.015000 (-9.37%)
Prev close: $0.160100
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kent Cunningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.50M
- Employees
- 11
- P/E (TTM)
- 0.05
- P/B (TTM)
- 8.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2025 (Q2)
|
$-0.74 | $0.00 | +0.0000 | +0.00% |
|
Mar 2025 (Q1)
|
$-0.37 | $0.00 | +0.0000 | +0.00% |
|
Dec 2024 (Q4)
|
$-0.50 | $-0.10 | -0.3980 | -390.20% |
|
Sep 2024 (Q3)
|
$-0.54 | $-0.06 | -0.4788 | -782.35% |
Financial Statements
| Depreciation and Amortization | $31.00K |
| Income/Loss From Continuing Operations After Tax | $27.73M |
| Income/Loss From Continuing Operations Before Tax | $27.73M |
| Income/Loss From Discontinued Operations Net Of Tax | -$36.37M |
| Net Income/Loss | -$8.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $36.37M |
| Net Income/Loss Attributable To Parent | -$45.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$45.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.13 |
| Diluted Earnings Per Share | -$2.13 |
| Basic Average Shares | 21,107,043 |
| Diluted Average Shares | 21,107,043 |
| Assets | $8.40M |
| Current Assets | $8.13M |
| Inventory | $2.08M |
| Other Current Assets | $6.05M |
| Noncurrent Assets | $276.00K |
| Fixed Assets | $88.00K |
| Other Non-current Assets | $188.00K |
| Liabilities | $8.00M |
| Current Liabilities | $3.54M |
| Accounts Payable | $2.15M |
| Other Current Liabilities | $1.40M |
| Noncurrent Liabilities | $4.45M |
| Equity | $407.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $407.00K |
| Liabilities And Equity | $8.40M |
| Net Cash Flow From Operating Activities | -$8.14M |
| Net Cash Flow From Operating Activities, Continuing | -$8.14M |
| Net Cash Flow From Investing Activities | $5.91M |
| Net Cash Flow From Investing Activities, Continuing | $5.91M |
| Net Cash Flow From Financing Activities | $12.17M |
| Net Cash Flow From Financing Activities, Continuing | $12.17M |
| Net Cash Flow | $9.93M |
| Net Cash Flow, Continuing | $9.93M |
| Comprehensive Income/Loss | -$47.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$47.41M |
| Other Comprehensive Income/Loss | -$38.77M |